References - Therapeutic Strategies in Cancer Biology and Pathology - page 215

antilymphangiogenic activity and suppresses lymph node metastasis. Am. J. Pathol. 176,
1950-1958.
Helland, A., Anglesio, M.S., George, J., Cowin, P.A., Jonstone, C.N., House, C.M., et al.
2011. Deregulation of MycN, Lin28B, and Let7 in a molecular subtype of aggressive
high grade serous ovarian cancers. Plos One 6, e18064.
Hemmati, P.G., Guener, D., Gillissen, B., Wendt, J., von Haefen, C., Chinnadurai, G., et al.
2006. Bak functionally complements for loss of Bax during p14(ARF)-induced mito-
chondrial apoptosis in human cancer cells. Oncogene 25, 6582-6594.
Hemmati, P.G., Normand, G., Gillissen, B., Wendt, J., Doerken, B., Daniel, P.T., 2008.
Cooperative effect of p21(Cip1/WAF-1) and 14-3-3 sigma on cell cycle arrest and apop-
tosis induction by p14(ARF. Oncogene 27, 6707-6719.
Hendrix, M.J.C., 2000. De-mystifying the mechanism(s) of maspin. Nature Med. 6, 374-376.
Hergovich, A., 2012. Mammalian Hippo signalling: a kinase network regulated by protein-
protein interactions. Biochem. Soc. Trans. 40, 124-128.
Hermeking, H., 2003. The 14-3-3 cancer connection. Nature Rev. Cancer 3, 931-943.
Herzog, A., Kindermann, B., Doring, F., Daniel, H., Wenzel, U., 2004. Pleiotropic molecular
effects of the pro-apoptotic dietary constituent flavone in human colon cancer cells iden-
tified by protein and mRNA expression profiling. Proteomics 4, 2455-2464.
Hesling, C., D'Incan, M., Mansard, S., Franck, F., Corbin-Duval, A., Chevenet, C., et al.,
2004. In vivo and in situ modulation of the expression of genes involved in metastasis
and angiogenesis in a patient treated with topical imiquimod for melanoma skin metasta-
ses. Br. J. Dermatol. 150, 761-767.
Heyn, H., Engelmann, M., Schreek, S., Ahrens, P., Lehmann, U., Kreipe, H., et al. 2011.
MicroRNA miR-335 is crucial for the BRCA1 regulatory cascade in breast cancer devel-
opment. Int. J. Cancer 129, 2797-2806.
Hickok, J.R., Sahni, S., Mikhed, Y., Bonini, M.G., Thomas, D.D., 2011. Nitric oxide sup-
presses tumor cell migration through N-Myc downstream-regulated gene-1 (NDRG1)
expression. Role of chelatable iron. J. Biol. Chem. 286, 41413-41424.
Hill, V.K., Dunwell, T., Catchpoole, D., Krex, D., Brini, A.T., Griffiths, M., et al., 2011.
Frequent epigenetic inactivation of KIBRA, an upstream member of the Salvador/Warts/
Hippo (SWH) tumor suppressor network, is associated with specific genetic event in
B-cell acute lymphocytic leukemia. Epigenetics 6, 326-332.
Hirai, K., Koizumi, K., Haraguchi, S., Hirata, T., Mikami, I., Fukushima, M., et al., 2005.
Prognostic significance of the tumor suppressor gene maspin in non-small cell lung can-
cer. Ann. Thor. Surg. 79, 248-253.
Hirasawa, M., Noda, K., Noda, S., Suzuki, M., Ozawa, Y., Shinoda, K., et al., 2011.
Transcriptional factors associated with epithelial-mesenchymal transition in choroidal
neovascularization. Mol. Vis. 17, 1222-1230.
Hirsch, H.A., Iliopoulos, D., Tsichlis, P.N., Struhl, K., 2009. Metformin selectively targets
cancer stem cells and acts together with chemotherapy to block tumor growth and pro-
long remission. Cancer Res. 69, 7507-7511.
Hisaoka, M., Tanaka, A., Hashimoto, H., 2002. Molecular alterations of h-warts/LATS1 tumor
suppressor in human soft tissue sarcoma. Lab. Invest. 82, 1427-1435.
Hisaoka, M., Matsuyama, A., Nagao, Y., Luan, L., Kuroda, T., Akiyama, H., et al., 2011.
Identification of altered microRNA expression patterns in synovial sarcoma. Genes
Chromosomes Cancer 50, 137-145.
Ho, J., Cocolakis, E., Dumas, V.M., Posner, B.I., Laporte, P.A., Lebrun, J.J., 2005. The G
protein-coupled receptor kinase-2 is a TGFbeta-inducible antagonist of TGFbeta signal
transduction. EMBO J. 24, 3247-3258.